AlphaCore Capital’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $505K | Buy |
12,993
+2,386
| +22% | +$92.7K | 0.02% | 361 |
|
|
2025
Q1 | $415K | Buy |
10,607
+590
| +6% | +$23.1K | 0.04% | 296 |
|
|
2024
Q4 | $339K | Sell |
10,017
-3,626
| -27% | -$123K | 0.07% | 153 |
|
|
2024
Q3 | $563K | Sell |
13,643
-465
| -3% | -$19.2K | 0.13% | 106 |
|
|
2024
Q2 | $548K | Buy |
14,108
+467
| +3% | +$18.2K | 0.13% | 97 |
|
|
2024
Q1 | $590K | Buy |
13,641
+17
| +0.1% | +$736 | 0.16% | 87 |
|
|
2023
Q4 | $511K | Sell |
13,624
-2,713
| -17% | -$102K | 0.07% | 140 |
|
|
2023
Q3 | $592K | Buy |
16,337
+1
| +0% | +$36 | 0.09% | 132 |
|
|
2023
Q2 | $582K | Buy |
+16,336
| New | +$582K | 0.09% | 131 |
|
|
2020
Q2 | – | Sell |
-98
| Closed | -$5K | – | 173 |
|
|
2020
Q1 | $5K | Buy |
+98
| New | +$5K | ﹤0.01% | 254 |
|